TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pharmaq AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,989,863
|
2,158,167
|
1,551,274 |
| Financial expenses |
56,666
|
14,004
|
80,018 |
| Earnings before taxes |
1,227,365
|
1,381,036
|
772,656 |
| Total assets |
4,993,091
|
3,995,280
|
2,834,967 |
| Current assets |
4,594,860
|
3,579,672
|
2,411,007 |
| Current liabilities |
484,151
|
465,611
|
390,571 |
| Equity capital |
4,465,808
|
3,521,526
|
2,443,513 |
| - share capital |
17,167
|
17,167
|
17,167 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
89.4%
|
88.1%
|
86.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
61.7%
|
64.0%
|
49.8% |
| Return on assets (ROA) |
25.7%
|
34.9%
|
30.1% |
| Current ratio |
949.1%
|
768.8%
|
617.3% |
| Return on equity (ROE) |
27.5%
|
39.2%
|
31.6% |
| Change turnover |
-168,304
|
606,893
|
326,867 |
| Change turnover % |
-8%
|
39%
|
27% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.